Products for Research Use Only
RegisterLogin

Levofloxacin (sodium)

CAT: 0804-HY-B0330CSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0330CSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Levofloxacin ((-) -Ofloxacin) sodium is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin sodium inhibits the DNA gyrase and topoisomerase IV. Levofloxacin sodium can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin sodium shows anti-orthopoxvirus activity[1][2][3][4][5].
CAS Number
872606-49-0
Product Name Alternative
(-) -Ofloxacin (sodium)
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Antibiotic; Bacterial; DNA/RNA Synthesis; Orthopoxvirus; Topoisomerase
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/levofloxacin-sodium.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(F)=C(N3CCN(CC3)C)C4=C2N(C=C1C(O[Na])=O)[C@@H](C)CO4
Molecular Formula
C18H19FN3NaO4
Molecular Weight
383.35
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Smee DF, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57 (1-2) :41-52.|[2]Siva, R., et al., Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis, 2014. 9: p. 179-86.|[3]Pradeep, A.R., et al., Clinical and microbiological effects of levofloxacin in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J Investig Clin Dent, 2014.|[4]Lee, B.T., et al., Efficacy of Levofloxacin in the Treatment of BK Viremia: A Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial. Clin J Am Soc Nephrol, 2014.|[5]Drlica K, et al. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61 (3) :377-92.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName
HY-W744235Levofloxacin-d3 (sodium)
HY-B0330-01Levofloxacin
HY-W338859Levofloxacin (mesylate)
HY-B0330R-01Levofloxacin (Standard)
HY-134226-01Defluoro Levofloxacin
HY-B0330A-01Levofloxacin (hydrate)
HY-B0330S-01Levofloxacin-d8
HY-B0330B-01Levofloxacin (hydrochloride)
HY-135389-01Desmethyl Levofloxacin
HY-B0330BSLevofloxacin-d8 (hydrochloride)

Alternative Products

CatalogName
T1451L-01Levofloxacin sodium
453692Levofloxacin-d3 Sodium Salt
B1959-5.1Levofloxacin

Popular Products